IUHP Advanced Praxis Case Management: Role of Genetic Evaluation and Testing in Pediatric Hypertrophic Cardiomyopathy


Date
Friday, September 16, 2016 - Saturday, September 16, 2017 12:00 AM   Online, IN

Overview
Jointly Provided - Enduring Materials

Objectives
At the conclusion of this activity, participants should be able to:
  1. Identify the potential sequelae of pediatric cardiomyopathies.
  2. Review the differential diagnosis of pediatric hypertrophic cardiomyopathy (HCM).
  3. Summarize the benefits of establishing the precise cause of pediatric HCM.
  4. Discuss the role of genetic testing in children with the clinical diagnosis of HCM.
  5. Review the established guidelines for HCM family screening.
  6. Describe the management of pediatric HCM.

Accreditation

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Indiana University School of Medicine and IU Health Physicians. Indiana University School of Medicine is accredited by the ACCME to provide continuing medical education for physicians.

Indiana University School of Medicine designates this enduring material for a maximum of 1.00 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.


For questions about accessibility or to request accommodations please contact the CME office at 317-274-0104 or cme@iu.edu. One week advance notice will allow us to provide seamless access. Please ensure to specify the accommodations you need in order to participate.